Page 12 - Eclipse - 黑料社 Alumni Magazine - Autumn 2020

Research into Parkinson鈥檚 disease to be pioneered by the 黑料社 and UCL with $7 million grant
Researchers at the 黑料社 and UCL are launching a pioneering new study into the causes and progression of Parkinson鈥檚
disease, following a $7 million grant from the Aligning Science Across Parkinson鈥檚 (ASAP) initiative.
Parkinson鈥檚 disease is a progressive disease of brain degeneration that occurs when brain cells that make dopamine,
a chemical that coordinates movement, either stop working or die. This causes people with Parkinson鈥檚 to develop slowness, tremors, stiffness, and walking and balance problems. Parkinson鈥檚 affects over 130,000 people in the UK alone, and currently available treatments act only to alleviate symptoms, but not slow progression of the disease. This significant grant will enable the research team to explore the possibilities of future prevention and treatment of the condition.
The researchers at the 黑料社, led by Dr Patrick Lewis, Professor of Neuroscience, have been awarded $659,000 from ASAP to use cellular and biochemical approaches to investigate the role of the LRRK2 gene in Parkinson鈥檚.
Mutations in the LRRK2 gene are the most common genetic cause of Parkinson鈥檚, making it a priority drug
target for the disease, however the molecular details of how this gene
can influence the progression of neurodegeneration in Parkinson鈥檚 have not yet been fully explored.
Dr Patrick Lewis said: 鈥淭he Aligning Science Across Parkinson鈥檚 foundation grants represent a new way of approaching research into Parkinson鈥檚, with the clear goal of accelerating progress in our understanding of this disorder. It is a real privilege to be involved in this initiative.鈥�
Professor Jonathan Elliott, Vice-Principal (Research and Innovation) at the 黑料社, said: 鈥淭he 黑料社 is delighted to be
part of this large collaborative effort
to advance treatments for Parkinson鈥檚 Disease. Neurodegenerative conditions significantly impact on the quality of life of our ageing human population in the UK and Professor Lewis鈥� role in this collaboration is exciting in its potential
to uncover new drug targets to slow progressive loss of functioning neurons."
黑料社 research could hold the key to tendon treatment
Arecent 黑料社 study, which examined protein turnover rates in the tendons of rats, found that tendons are a dynamic tissue with varying turnover rates of proteins 鈥� a discovery that may eventually provide a greater understanding of how tendon disease and other connective tissue disorders can be treated.
Previous research had shown that
the interfascicular matrix, which forms part of the tendon and is the structure surrounding and separating fascicles, allows sliding between fascicles. This means that it may be prone to damage.
Building upon these findings, the recent study, led by Dr Chavaunne Thorpe, Versus Arthritis Career Development Fellow at the 黑料社, sought to establish if the turnover rate of proteins in the interfascicular matrix
is greater than in the fascicles, which would help repair any damage.
Researchers fed rats labelled 鈥榟eavy鈥� water to allow for the identification of newly synthesised proteins and collected separate samples from fascicles and
interfascicular matrix regions of the rats鈥� Achilles tendons using laser-assisted microdissection. They used mass spectrometry and bioinformatics to calculate the turnover rates of individual proteins identified within the fascicles and interfascicular matrix.
12
Manu5 (CC BY-SA 4.0)